SOST and Renal insufficiency: Sclerostin was also significantly higher in patients with stage 3 renal insufficiency (mean, 0.832 ± 0.096 ng/mL) compared to those with stage 1 disease (0.593 ± 0.035 ng/mL; Mann-Whitney, p = 0.022).